A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold

Histone deacetylases (HDACs) are enzymes involved in many important biological functions. They have been linked to a variety of cancers, psychiatric disorders, and other diseases. Since small molecules can serve as probes to study the relevant biological roles of HDACs, novel scaffolds are necessary...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2011-07, Vol.21 (14), p.4164-4169
Hauptverfasser: Kemp, Melissa M., Wang, Qiu, Fuller, Jason H., West, Nathan, Martinez, Nicole M., Morse, Elizabeth M., Weïwer, Michel, Schreiber, Stuart L., Bradner, James E., Koehler, Angela N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4169
container_issue 14
container_start_page 4164
container_title Bioorganic & medicinal chemistry letters
container_volume 21
creator Kemp, Melissa M.
Wang, Qiu
Fuller, Jason H.
West, Nathan
Martinez, Nicole M.
Morse, Elizabeth M.
Weïwer, Michel
Schreiber, Stuart L.
Bradner, James E.
Koehler, Angela N.
description Histone deacetylases (HDACs) are enzymes involved in many important biological functions. They have been linked to a variety of cancers, psychiatric disorders, and other diseases. Since small molecules can serve as probes to study the relevant biological roles of HDACs, novel scaffolds are necessary to develop more efficient, selective drug candidates. Screening libraries of molecules may yield structurally diverse probes that bind these enzymes and modulate their functions in cells. Here we report a small molecule with a novel hydroxy-pyrimidine scaffold that inhibits multiple HDAC enzymes and modulates acetylation levels in cells. Analogs were synthesized in an effort to evaluate structure–activity relationships.
doi_str_mv 10.1016/j.bmcl.2011.05.098
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3248787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X11007396</els_id><sourcerecordid>883039832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-9aac8c7eecb5c60390cac7c22e8cd3d1d2208d001c35d9f13f37e090f79a036b3</originalsourceid><addsrcrecordid>eNqFkc2O0zAURi0EYsrAC7CAbBCrhOvYcWwJIVXlZ5BGYgEjsbOca2fqKo2LnRb69jhqGWADKy987ufP9xDylEJFgYpXm6rb4lDVQGkFTQVK3iMLygUvGYfmPlmAElBKxb9ekEcpbQAoB84fkouaCiVUIxZELYsxHNxQXL1drgo_rn3npxCL735aF6ZYH20MP47l7hj91ls_uiKh6fsw2MfkQW-G5J6cz0ty8_7dl9VVef3pw8fV8rrEhsNUKmNQYuscdg0KYArQYIt17SRaZqmta5A2V0PWWNVT1rPWgYK-VQaY6NgleXPK3e27rbPoximaQe9yIROPOhiv_74Z_VrfhoNmNZetbHPAy3NADN_2Lk166xO6YTCjC_ukpWS5lmT1_8mW50gKM1mfSIwhpej6uz4U9CxHb_QsR89yNDQ6y8lDz_78yd3ILxsZeHEGTN7y0Eczok-_Oc44EzBzz09cb4I2tzEzN5_zS01eI2tA8Ey8PhEumzl4F3VC70Z01keHk7bB_6vpTwd2tps</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>874487102</pqid></control><display><type>article</type><title>A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Collection</source><creator>Kemp, Melissa M. ; Wang, Qiu ; Fuller, Jason H. ; West, Nathan ; Martinez, Nicole M. ; Morse, Elizabeth M. ; Weïwer, Michel ; Schreiber, Stuart L. ; Bradner, James E. ; Koehler, Angela N.</creator><creatorcontrib>Kemp, Melissa M. ; Wang, Qiu ; Fuller, Jason H. ; West, Nathan ; Martinez, Nicole M. ; Morse, Elizabeth M. ; Weïwer, Michel ; Schreiber, Stuart L. ; Bradner, James E. ; Koehler, Angela N.</creatorcontrib><description>Histone deacetylases (HDACs) are enzymes involved in many important biological functions. They have been linked to a variety of cancers, psychiatric disorders, and other diseases. Since small molecules can serve as probes to study the relevant biological roles of HDACs, novel scaffolds are necessary to develop more efficient, selective drug candidates. Screening libraries of molecules may yield structurally diverse probes that bind these enzymes and modulate their functions in cells. Here we report a small molecule with a novel hydroxy-pyrimidine scaffold that inhibits multiple HDAC enzymes and modulates acetylation levels in cells. Analogs were synthesized in an effort to evaluate structure–activity relationships.</description><identifier>ISSN: 0960-894X</identifier><identifier>ISSN: 1464-3405</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2011.05.098</identifier><identifier>PMID: 21696956</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Acetylation ; Analytical, structural and metabolic biochemistry ; Biological and medical sciences ; drugs ; Enzymes and enzyme inhibitors ; Fundamental and applied biological sciences. Psychology ; Histone deacetylase ; Histone Deacetylase Inhibitors - chemical synthesis ; Histone Deacetylase Inhibitors - chemistry ; Histone Deacetylase Inhibitors - pharmacology ; Histone Deacetylases - chemistry ; Histone Deacetylases - metabolism ; Humans ; Hydrolases ; Hydroxy-pyrimidine ; Medical sciences ; Miscellaneous ; neoplasms ; Non-selective inhibitor ; Pharmacology. Drug treatments ; Pyrimidines - chemical synthesis ; Pyrimidines - chemistry ; Pyrimidines - pharmacology ; SAR studies ; screening ; Structure-Activity Relationship ; structure-activity relationships</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2011-07, Vol.21 (14), p.4164-4169</ispartof><rights>2011 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><rights>2011 Elsevier Ltd. All rights reserved. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-9aac8c7eecb5c60390cac7c22e8cd3d1d2208d001c35d9f13f37e090f79a036b3</citedby><cites>FETCH-LOGICAL-c540t-9aac8c7eecb5c60390cac7c22e8cd3d1d2208d001c35d9f13f37e090f79a036b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2011.05.098$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24343606$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21696956$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kemp, Melissa M.</creatorcontrib><creatorcontrib>Wang, Qiu</creatorcontrib><creatorcontrib>Fuller, Jason H.</creatorcontrib><creatorcontrib>West, Nathan</creatorcontrib><creatorcontrib>Martinez, Nicole M.</creatorcontrib><creatorcontrib>Morse, Elizabeth M.</creatorcontrib><creatorcontrib>Weïwer, Michel</creatorcontrib><creatorcontrib>Schreiber, Stuart L.</creatorcontrib><creatorcontrib>Bradner, James E.</creatorcontrib><creatorcontrib>Koehler, Angela N.</creatorcontrib><title>A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Histone deacetylases (HDACs) are enzymes involved in many important biological functions. They have been linked to a variety of cancers, psychiatric disorders, and other diseases. Since small molecules can serve as probes to study the relevant biological roles of HDACs, novel scaffolds are necessary to develop more efficient, selective drug candidates. Screening libraries of molecules may yield structurally diverse probes that bind these enzymes and modulate their functions in cells. Here we report a small molecule with a novel hydroxy-pyrimidine scaffold that inhibits multiple HDAC enzymes and modulates acetylation levels in cells. Analogs were synthesized in an effort to evaluate structure–activity relationships.</description><subject>Acetylation</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Biological and medical sciences</subject><subject>drugs</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Histone deacetylase</subject><subject>Histone Deacetylase Inhibitors - chemical synthesis</subject><subject>Histone Deacetylase Inhibitors - chemistry</subject><subject>Histone Deacetylase Inhibitors - pharmacology</subject><subject>Histone Deacetylases - chemistry</subject><subject>Histone Deacetylases - metabolism</subject><subject>Humans</subject><subject>Hydrolases</subject><subject>Hydroxy-pyrimidine</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>neoplasms</subject><subject>Non-selective inhibitor</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - chemistry</subject><subject>Pyrimidines - pharmacology</subject><subject>SAR studies</subject><subject>screening</subject><subject>Structure-Activity Relationship</subject><subject>structure-activity relationships</subject><issn>0960-894X</issn><issn>1464-3405</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2O0zAURi0EYsrAC7CAbBCrhOvYcWwJIVXlZ5BGYgEjsbOca2fqKo2LnRb69jhqGWADKy987ufP9xDylEJFgYpXm6rb4lDVQGkFTQVK3iMLygUvGYfmPlmAElBKxb9ekEcpbQAoB84fkouaCiVUIxZELYsxHNxQXL1drgo_rn3npxCL735aF6ZYH20MP47l7hj91ls_uiKh6fsw2MfkQW-G5J6cz0ty8_7dl9VVef3pw8fV8rrEhsNUKmNQYuscdg0KYArQYIt17SRaZqmta5A2V0PWWNVT1rPWgYK-VQaY6NgleXPK3e27rbPoximaQe9yIROPOhiv_74Z_VrfhoNmNZetbHPAy3NADN_2Lk166xO6YTCjC_ukpWS5lmT1_8mW50gKM1mfSIwhpej6uz4U9CxHb_QsR89yNDQ6y8lDz_78yd3ILxsZeHEGTN7y0Eczok-_Oc44EzBzz09cb4I2tzEzN5_zS01eI2tA8Ey8PhEumzl4F3VC70Z01keHk7bB_6vpTwd2tps</recordid><startdate>20110715</startdate><enddate>20110715</enddate><creator>Kemp, Melissa M.</creator><creator>Wang, Qiu</creator><creator>Fuller, Jason H.</creator><creator>West, Nathan</creator><creator>Martinez, Nicole M.</creator><creator>Morse, Elizabeth M.</creator><creator>Weïwer, Michel</creator><creator>Schreiber, Stuart L.</creator><creator>Bradner, James E.</creator><creator>Koehler, Angela N.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20110715</creationdate><title>A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold</title><author>Kemp, Melissa M. ; Wang, Qiu ; Fuller, Jason H. ; West, Nathan ; Martinez, Nicole M. ; Morse, Elizabeth M. ; Weïwer, Michel ; Schreiber, Stuart L. ; Bradner, James E. ; Koehler, Angela N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-9aac8c7eecb5c60390cac7c22e8cd3d1d2208d001c35d9f13f37e090f79a036b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acetylation</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Biological and medical sciences</topic><topic>drugs</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Histone deacetylase</topic><topic>Histone Deacetylase Inhibitors - chemical synthesis</topic><topic>Histone Deacetylase Inhibitors - chemistry</topic><topic>Histone Deacetylase Inhibitors - pharmacology</topic><topic>Histone Deacetylases - chemistry</topic><topic>Histone Deacetylases - metabolism</topic><topic>Humans</topic><topic>Hydrolases</topic><topic>Hydroxy-pyrimidine</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>neoplasms</topic><topic>Non-selective inhibitor</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - chemistry</topic><topic>Pyrimidines - pharmacology</topic><topic>SAR studies</topic><topic>screening</topic><topic>Structure-Activity Relationship</topic><topic>structure-activity relationships</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kemp, Melissa M.</creatorcontrib><creatorcontrib>Wang, Qiu</creatorcontrib><creatorcontrib>Fuller, Jason H.</creatorcontrib><creatorcontrib>West, Nathan</creatorcontrib><creatorcontrib>Martinez, Nicole M.</creatorcontrib><creatorcontrib>Morse, Elizabeth M.</creatorcontrib><creatorcontrib>Weïwer, Michel</creatorcontrib><creatorcontrib>Schreiber, Stuart L.</creatorcontrib><creatorcontrib>Bradner, James E.</creatorcontrib><creatorcontrib>Koehler, Angela N.</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kemp, Melissa M.</au><au>Wang, Qiu</au><au>Fuller, Jason H.</au><au>West, Nathan</au><au>Martinez, Nicole M.</au><au>Morse, Elizabeth M.</au><au>Weïwer, Michel</au><au>Schreiber, Stuart L.</au><au>Bradner, James E.</au><au>Koehler, Angela N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2011-07-15</date><risdate>2011</risdate><volume>21</volume><issue>14</issue><spage>4164</spage><epage>4169</epage><pages>4164-4169</pages><issn>0960-894X</issn><issn>1464-3405</issn><eissn>1464-3405</eissn><abstract>Histone deacetylases (HDACs) are enzymes involved in many important biological functions. They have been linked to a variety of cancers, psychiatric disorders, and other diseases. Since small molecules can serve as probes to study the relevant biological roles of HDACs, novel scaffolds are necessary to develop more efficient, selective drug candidates. Screening libraries of molecules may yield structurally diverse probes that bind these enzymes and modulate their functions in cells. Here we report a small molecule with a novel hydroxy-pyrimidine scaffold that inhibits multiple HDAC enzymes and modulates acetylation levels in cells. Analogs were synthesized in an effort to evaluate structure–activity relationships.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>21696956</pmid><doi>10.1016/j.bmcl.2011.05.098</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2011-07, Vol.21 (14), p.4164-4169
issn 0960-894X
1464-3405
1464-3405
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3248787
source MEDLINE; Elsevier ScienceDirect Journals Collection
subjects Acetylation
Analytical, structural and metabolic biochemistry
Biological and medical sciences
drugs
Enzymes and enzyme inhibitors
Fundamental and applied biological sciences. Psychology
Histone deacetylase
Histone Deacetylase Inhibitors - chemical synthesis
Histone Deacetylase Inhibitors - chemistry
Histone Deacetylase Inhibitors - pharmacology
Histone Deacetylases - chemistry
Histone Deacetylases - metabolism
Humans
Hydrolases
Hydroxy-pyrimidine
Medical sciences
Miscellaneous
neoplasms
Non-selective inhibitor
Pharmacology. Drug treatments
Pyrimidines - chemical synthesis
Pyrimidines - chemistry
Pyrimidines - pharmacology
SAR studies
screening
Structure-Activity Relationship
structure-activity relationships
title A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T17%3A50%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20HDAC%20inhibitor%20with%20a%20hydroxy-pyrimidine%20scaffold&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Kemp,%20Melissa%20M.&rft.date=2011-07-15&rft.volume=21&rft.issue=14&rft.spage=4164&rft.epage=4169&rft.pages=4164-4169&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2011.05.098&rft_dat=%3Cproquest_pubme%3E883039832%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=874487102&rft_id=info:pmid/21696956&rft_els_id=S0960894X11007396&rfr_iscdi=true